OQROStart free trial
Politician trade (House)

Johnson & Johnson (JNJ): Rep. Blake D. Moore (UT01) disclosed a sale $1K–$15K

Rep. Blake D. Moore (UT01) disclosed a sale of Johnson & Johnson in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
5 days
Disclosure lag
Traded
Jan 19, 2024
Disclosed
Jan 24, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 5, 2023Congress · 2 peopleMembers of Congress: 2 purchases
  2. Dec 14, 2023Congress · 1 personMembers of Congress: 2 sales
  3. Jan 19, 2024 · this disclosureCongressDisclosed sale of JNJ — reported range $1,001 - $15,000

What came next

  1. Jan 19, 2024CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  2. Jan 23, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  3. Mar 5, 2024Congress · 2 peopleMembers of Congress: 2 purchases
  4. Mar 21, 2024FDAFDA device clearance: DePuy Synthes VOLT Mini Fragment Plating System, DePuy Synthes VOLT Small Fragment Plating System
  5. Mar 21, 2024FDAFDA device clearance: ATTUNE Total Knee System, ATTUNE Cementless Knee System, LPS Limb Preservation System, Sigma High Performance (HP) Partial Knee System
  6. Mar 22, 2024FDAFDA drug approval: Opsynvi
  7. Mar 22, 2024FDAFDA device clearance: Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripheral IVL Catheter
  8. Apr 4, 2024FDAFDA device clearance: PINNACLETM Constrained Acetabular Liners
  9. Apr 23, 2024FDARecall: SURGIFOAM" Absorbable Gelatin Powder Kit, Product Code 1979.
  10. Apr 25, 2024FDARecall: STARDRIVE SCRWDRVR SHFT/T4 50MM/SELF-RETAINING/HXC-Intended for tightening, loosening, or removing of screw implants during orthopaedic surgery. Part Number: 0…
  11. May 7, 2024FDAFDA device clearance: Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave L6 Peripheral IVL Catheter
  12. May 9, 2024FDAFDA device clearance: DePuy Synthes MatrixSTERNUM Fixation System
  13. May 10, 2024FDARecall: PDS Plus Antibacterial (polydioxanone) Suture - Intended for use in general soft tissue approximation, including use in paediatric cardiovascular tissue, in mi…
  14. May 10, 2024FDARecall: MONOCRYL (poliglecaprone 25) Suture - Intended for use in general soft tissue approximation and/or ligation where an absorbable material is indicated PRODUCT C…
  15. May 10, 2024FDARecall: VICRYL (polyglactin 910) Suture - Indicated for use in general soft tissue approximation and/or ligation, including use in ophthalmic surgery, but not for use…
  16. May 10, 2024FDARecall: PDS II (polydioxanone) Suture - Intended for use in general soft tissue approximation, including use in paediatric cardiovascular tissue, in microsurgery and i…
  17. May 10, 2024FDARecall: VICRYL Plus Antibacterial (polyglactin 910) Suture - Indicated for use in general soft tissue approximation and/or ligation, except for ophthalmic, cardiovascu…
  18. May 10, 2024FDARecall: MONOCRYL Plus Antibacterial (poliglecaprone 25) Suture - Intended for use in general soft tissue approximation and/or ligation where an absorbable material is…
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Rep. Blake D. Moore (UT01)

The full history of Rep. Blake D. Moore (UT01) is on the profile page.

How this filing works

Explore the data

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data